HealdR.J., MoranB.J., RyallR.D., SextonR., MacFarlaneJ.R.: Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978-1997.Arch Surg, 133: 894–899, 1998.
2.
MerchantN.B., GuillemJ.G., PatyP.B., EnkerW.E., MinskyB.D., QuanS.H., WongD., CohenA.M.: T3N0 Rectal Cancer: results following sharp mesorectal excision and no adjuvant therapy.J Gastrointest Surg, 3: 642–647, 1999.
3.
ArenasR.B., FicheraA., MhoonD., MichelassiF.: Total mesenteric excision in the surgical treatment of rectal cancer. A prospective study.Arch Surg, 133: 608–612, 1998.
4.
Swedish Rectal Cancer Trial: Improved survival with preoperative radiotheapy in resectable rectal cancer.N Engl J Med, 336: 980–987, 1997.
ValentiniV., CocoC., CelliniN., PicciocchiA., RosettoM.E., MantiniG., MarmiroliL., BarbaroB., CogliandoloS., NuzzoG., TedescoM., Ambesi-ImpiombatoF., CosimelliM., RotmanM.: Preoperative chemoradiation with CDDP and 5-FU for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, sphincter preservation.Int J Radiat Oncol Biol Phys, 45: 1175–1184, 1999.
7.
KapiteijnE., KranenbargE.K., SteupW.H., TaatC.W., RuttenH.J., WiggersT., van KriekenJ.H., HermansJ., LeerJ.W., van de VeldeC.J.: Total mesorectal excision (TME) with or without preoperative radiotherapy in the treatment of primary rectal cancer. Prospective randomised trial with standard operative and histopathological techniques. Dutch Colorectal Cancer Group.Eur J Surg, 165: 410–420, 1999.
8.
BuglioniS., D'AgnanoI., CosimelliM., VasselliS., D'AngeloC., TedescoM., ZupiG., MottoleseM.: Evaluation of multiple bio-pathological factors in colorectal adenocarcinomas: independent prognostic role of p53 and Bcl-2.Int J Cancer, 84: 545–552, 1999.
